This clinical study focuses on male infertility, specifically the role of sperm DNA fragmentation in reproductive health. Conducted as a prospective trial, it evaluates the impact of Dfrag® tablets: a nutraceutical blend of antioxidants and micronutrients over a 3-month period. The research assesses changes in sperm DNA fragmentation index (DFI) and key semen parameters before and after supplementation.